Informa (LON:INF) Stock Crosses Above Two Hundred Day Moving Average – What’s Next?

Informa plc (LON:INF) shares passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 813.87 ($10.94) and traded as high as GBX 935.60 ($12.58). Informa shares last traded at GBX 929.80 ($12.50), with a volume of 2,490,894 shares traded.

Wall Street Analysts Forecast Growth

Separately, JPMorgan Chase & Co. started coverage on shares of Informa in a research note on Wednesday, September 3rd. They issued an “overweight” rating and a GBX 1,020 price objective on the stock. Two equities research analysts have rated the stock with a Buy rating, Based on data from MarketBeat, the company presently has an average rating of “Buy” and an average price target of GBX 975.

Informa Price Performance

The stock has a market capitalization of £12.00 billion, a price-to-earnings ratio of 16,905.45, a PEG ratio of 0.75 and a beta of 1.12. The stock’s 50 day simple moving average is GBX 886.80 and its 200-day simple moving average is GBX 813.87. The company has a debt-to-equity ratio of 31.98, a current ratio of 0.56 and a quick ratio of 1.70.

Informa (LON:INF) last issued its quarterly earnings results on Wednesday, July 23rd. The company reported GBX 30.10 earnings per share for the quarter. Informa had a net margin of 9.30% and a return on equity of 4.75%. On average, analysts expect that Informa plc will post 59.3240265 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Stephen A. Carter sold 406,936 shares of Informa stock in a transaction on Tuesday, July 29th. The stock was sold at an average price of GBX 865, for a total transaction of £3,519,996.40. 0.41% of the stock is currently owned by company insiders.

Informa Company Profile

Our events, digital products and academic research services connect specialists with knowledge, helping them learn more, know more and do more.

We do this in dozens of specialist markets and subject matter categories, including in Healthcare & Pharma, Technology, Finance, Education, Marketing, Health & Nutrition, Foodservice, and many more.